Add this topic to your myFT Digest for news straight to your inbox
Busier lifestyles and demographic shifts help change consumer tastes
Health insurer’s results buoyed by higher operating income and reduction in medical care spending
Local manufacturers and retailers thrive as multinationals pull back
US pharma group had been preparing financing for a deal
Awards designed to offset charges resulting from $5.3bn takeover of Abbott unit
Drugs maker pushes on with Abbott unit purchase that will cut tax rate
What happens when a Morris Trust meets an inversion?
Portfolio of generic drugs snapped up
Shareholders in drugmakers involved in mergers have to worry about US capital gains tax
AbbVie and Shire are taking different routes to success
Big pharma faces new challenges, says Andrew Jack
Bristol-Myers Squibb is the interesting exception, but the time to deliver is arriving
Warburg Pincus’s audacity and opportunism is rewarded
International Edition